CompletedNCT00239759

MIRAGE: Multi-Institutional Research in Alzheimer's Genetic Epidemiology

Studying NON RARE IN EUROPE: Alzheimer disease

Last synced from ClinicalTrials.gov May 13, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: National Institute on Aging (NIA)
Principal Investigator: Lindsay Farrer, PhD
Chief, Genetics Program, Boston University
Enrollment: 2000 enrolled
Eligibility: 50 years · All sexes
Timeline: 2002 – 2008

Study locations (15)

University of Alabama, Birmingham, Alabama, United States
Sun Health Research Institute, Sun City, Arizona, United States
Rancho Los Amigos National Rehabilitation Center/University of Southern California, Downey, California, United States
University of California, Davis, Sacramento, California, United States
Howard University, Washington D.C., District of Columbia, United States
University of Miami School of Medicine, Miami Beach, Florida, United States
Morehouse School of Medicine, Atlanta, Georgia, United States
Pacific Health Research Institute, Honolulu, Hawaii, United States
Indiana University School of Medicine, Indianapolis, Indiana, United States
Boston University School of Medicine, Boston, Massachusetts, United States
Cornell Medical University, New York, New York, United States
Case Western Reserve University, Cleveland, Ohio, United States
University of British Columbia, Vancouver, British Columbia, Canada
Technical University of Munich, Munich, Germany
G. Papanicolaou Hospital, Exholi Thessaloniki, Greece

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00239759 on ClinicalTrials.gov

Other trials for NON RARE IN EUROPE: Alzheimer disease

Additional recruiting or active studies for the same condition.

See all trials for NON RARE IN EUROPE: Alzheimer disease →

← Back to all trials